Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beisi Xu

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Nature Communications|February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastomaMaged Zeineldin, Sara Federico, Xiang Chen, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Nature Communications|February 13, 2023
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemiaJennifer L Kamens, Stephanie Nance, Cary Koss, et al.
Cell Reports|March 18, 2026
Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumorAndrew M Fleming, Carolyn M Jablonowski, Hongjian Jin, et al.
Cancer Discovery|June 9, 2021
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell LeukemiaLindsey E Montefiori, Sonja Bendig, Zhaohui Gu, et al.
Nature|September 14, 2018
The genetic basis and cell of origin of mixed phenotype acute leukaemiaThomas B Alexander, Zhaohui Gu, Ilaria Iacobucci, et al.
Nature Genetics|November 8, 2016
Deregulation of DUX4 and ERG in acute lymphoblastic leukemiaJinghui Zhang, Kelly McCastlain, Hiroki Yoshihara, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Nature Communications|February 16, 2020
MYCN amplification and ATRX mutations are incompatible in neuroblastomaMaged Zeineldin, Sara Federico, Xiang Chen, et al.
Cancer Cell|August 28, 2018
Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic AnalysesElizabeth Stewart, Justina McEvoy, Hong Wang, et al.
Nature Communications|February 13, 2023
Proteasome inhibition targets the KMT2A transcriptional complex in acute lymphoblastic leukemiaJennifer L Kamens, Stephanie Nance, Cary Koss, et al.
Cell Reports|March 18, 2026
Developmental reprogramming underlies chemotherapy resistance in favorable-histology Wilms tumorAndrew M Fleming, Carolyn M Jablonowski, Hongjian Jin, et al.
Cancer Discovery|June 9, 2021
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell LeukemiaLindsey E Montefiori, Sonja Bendig, Zhaohui Gu, et al.
Nature|September 14, 2018
The genetic basis and cell of origin of mixed phenotype acute leukaemiaThomas B Alexander, Zhaohui Gu, Ilaria Iacobucci, et al.
Nature Genetics|November 8, 2016
Deregulation of DUX4 and ERG in acute lymphoblastic leukemiaJinghui Zhang, Kelly McCastlain, Hiroki Yoshihara, et al.
Pageof 11